Table 2 Univariate analyses of factors potentially associated with detection of CBD stones
No CBD stone detected (n = 65) | CBD stone detected (n = 28) | p value | |
|---|---|---|---|
Mean (±SD) age (years) | 58.85 (±16.09) | 65.26 (±13.76) | 0.06 |
Mean (±SD) alkaline phosphatase level (U/mL) | 147.40 (±127.55) | 226.30 (±192.64) | 0.02* |
Mean (±SD) total bilirubin level (mg/dL) | 3.19 (±5.20) | 2.57 (±2.33) | 0.54 |
Mean (±SD) SGOT level (U/L) | 215.13 (±176.86) | 215.13 (±250.75) | 0.13 |
Mean (±SD) SGPT level (U/L) | 137.07 (±210.94) | 198.65 (±184.04) | 0.17 |
Clinical classification | 0.06 | ||
Intermediate likelihood (n = 49) | 38 | 11 | |
High likelihood (n = 44) | 27 | 17 | |
Dilated CBD on transabdominal | |||
ultrasonography (n = 26) | 5 | 21 | 0.48 |
Mean (±SD) time interval (days) | 38.95 (±62.77) | 33.23 (±42.24) | 0.64 |
EUS performed within 7 days (n) | 14 | 14 | 0.02* |